Are you working in the field of immuno-oncology leveraging mRNA-LNP based therapeutic approaches? Then you probably already know about the importance of understanding the complex interactions of mRNA-LNPs with different types of immune and non-immune cells such as cancer cells. But do you know the best ways to get that information? In this 30 min presentation, Dr Frances Acklam, senior scientist at CLS will:
- Summarise the most common challenges associated with discovery of mRNA-LNP drug products
- Introduce different types of immune and non-immune cells and role they play in cancer
- Discuss how mRNA-LNP technology can be used to boost immune cells to combat cancer
